Caretta Therapeutics
West Des Moines
Iowa
United States
About Caretta Therapeutics
Caretta Therapeutics was formed by Spotlight Innovation in August 2016 to develop and commercialize products, derived from cobra and rattlesnake venom, that have potential analgesic properties. The products are intended to be available as over-the-counter formulations.YEAR FOUNDED:
August 2016
5 articles about Caretta Therapeutics
-
Spotlight Innovation Subsidiary Caretta Therapeutics Engages Public Relations Firm TransMedia Group
7/11/2017
-
Spotlight Innovation Subsidiary Caretta Therapeutics Signs Second Venodol Api Production Agreement
6/14/2017
-
Spotlight Innovation Subsidiary Caretta Therapeutics Begins The Manufacturing Process For Venodol, A New Over-The-Counter Product To Treat Chronic Pain
5/31/2017
-
Spotlight Innovation Release: Company Subsidiary Caretta Therapeutics Announces Venodol, A New Over-The-Counter Product To Treat Chronic Pain
1/18/2017
-
Spotlight Innovation's Newly Established Subsidiary Caretta Therapeutics Enters Into Exclusive Licensing Agreement To Develop And Commercialize Analgesic Products
10/6/2016